Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 61 entries
Sorted by: Best Match Show Resources per page
Direct and indirect influence of physical education-based interventions on physical activity: A review

education interventions

Slingerland M.
GSID: s803NTtKaGsJ
M Slingerland, L Borghouts - Journal of physical …, 2011 - journals.humankinetics.com

… A review of these studies showed that interventions are able to directly increase activity in PE classes with relatively simple modifications, … PA through interventions utilizing PE as a component is less convincing. Conclusions:We propose that evidence-based interventions...

Cite
Slingerland, M., & Borghouts, L. (2011). Direct and indirect influence of physical education-based interventions on physical activity: A review. Journal of physical activity and health, 8(6), 866-878.
Slingerland, Menno, and Lars Borghouts. "Direct and indirect influence of physical education-based interventions on physical activity: A review." Journal of physical activity and health 8.6 (2011): 866-878.
Copy Download .nbib Format: MLA
Model landforms: experimental fluvial geomorphology.

Science (New York, N.Y.)

Slingerland R.
PMID: 17796742
Science. 1988 Apr 15;240(4850):343. doi: 10.1126/science.240.4850.343.

No abstract available.

Cite
Slingerland R. Model landforms: experimental fluvial geomorphology. Science. 1988;240(4850):343doi: 10.1126/science.240.4850.343.
Slingerland, R. (1988). Model landforms: experimental fluvial geomorphology. Science (New York, N.Y.), 240(4850), 343. https://doi.org/10.1126/science.240.4850.343
Slingerland, R. "Model landforms: experimental fluvial geomorphology." Science (New York, N.Y.) vol. 240,4850 (1988): 343. doi: https://doi.org/10.1126/science.240.4850.343
Slingerland R. Model landforms: experimental fluvial geomorphology. Science. 1988 Apr 15;240(4850):343. doi: 10.1126/science.240.4850.343. PMID: 17796742.
Copy Download .nbib Format: NLM
Lapatinib: new opportunities for management of breast cancer.

Breast cancer (Dove Medical Press)

Liao J, Gallas M, Pegram M, Slingerland J.
PMID: 24367169
Breast Cancer (Dove Med Press). 2010 Nov 15;2:79-91. doi: 10.2147/BCTT.S5929.

Approximately 20% of new diagnosed breast cancers overexpress the human epidermal growth factor receptor 2 (EGFR2), also known as erythroblastic leukemia viral oncogene homolog 2 (ERBB2) protein, as a consequence of ERBB2 gene amplification, resulting in a poor prognosis....

Cite
Liao J, Gallas M, Pegram M, et al. Lapatinib: new opportunities for management of breast cancer. Breast Cancer (Dove Med Press). 2010;2:79-91doi: 10.2147/BCTT.S5929.
Liao, J., Gallas, M., Pegram, M., & Slingerland, J. (2010). Lapatinib: new opportunities for management of breast cancer. Breast cancer (Dove Medical Press), 279-91. https://doi.org/10.2147/BCTT.S5929
Liao, Julia, et al. "Lapatinib: new opportunities for management of breast cancer." Breast cancer (Dove Medical Press) vol. 2 (2010): 79-91. doi: https://doi.org/10.2147/BCTT.S5929
Liao J, Gallas M, Pegram M, Slingerland J. Lapatinib: new opportunities for management of breast cancer. Breast Cancer (Dove Med Press). 2010 Nov 15;2:79-91. doi: 10.2147/BCTT.S5929. PMID: 24367169; PMCID: PMC3846530.
Copy Download .nbib Format: NLM
A randomised, investigator-initiated, clinical trial of the effects of fentanyl on P2Y12-receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: rationale and design of the Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Tavenier AH, Hermanides RS, Ottervanger JP, Rasoul S, Slingerland RJ, Tolsma R, van Workum S, Kedhi E, van 't Hof AWJ.
PMID: 30767166
Neth Heart J. 2019 Apr;27(4):185-190. doi: 10.1007/s12471-019-1241-6.

BACKGROUND: Fast and accurate platelet inhibition is an important therapeutic goal in the acute treatment of patients with ST-elevation myocardial infarction (STEMI). Platelet inhibitory effects induced by oral P2Y12-receptor antagonists are delayed in STEMI patients undergoing primary percutaneous coronary...

Cite
Tavenier AH, Hermanides RS, Ottervanger JP, et al. A randomised, investigator-initiated, clinical trial of the effects of fentanyl on P2Y12-receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: rationale and design of the Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial. Neth Heart J. 2019;27(4):185-190doi: 10.1007/s12471-019-1241-6.
Tavenier, A. H., Hermanides, R. S., Ottervanger, J. P., Rasoul, S., Slingerland, R. J., Tolsma, R., van Workum, S., Kedhi, E., & van 't Hof, A. W. J. (2019). A randomised, investigator-initiated, clinical trial of the effects of fentanyl on P2Y12-receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: rationale and design of the Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 27(4), 185-190. https://doi.org/10.1007/s12471-019-1241-6
Tavenier, A H, et al. "A randomised, investigator-initiated, clinical trial of the effects of fentanyl on P2Y12-receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: rationale and design of the Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 27,4 (2019): 185-190. doi: https://doi.org/10.1007/s12471-019-1241-6
Tavenier AH, Hermanides RS, Ottervanger JP, Rasoul S, Slingerland RJ, Tolsma R, van Workum S, Kedhi E, van 't Hof AWJ. A randomised, investigator-initiated, clinical trial of the effects of fentanyl on P2Y12-receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: rationale and design of the Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial. Neth Heart J. 2019 Apr;27(4):185-190. doi: 10.1007/s12471-019-1241-6. PMID: 30767166; PMCID: PMC6439041.
Copy Download .nbib Format: NLM
Structure-Activity Studies with Bis-Amidines That Potentiate Gram-Positive Specific Antibiotics against Gram-Negative Pathogens.

ACS infectious diseases

Wesseling CMJ, Slingerland CJ, Veraar S, Lok S, Martin NI.
PMID: 34766746
ACS Infect Dis. 2021 Dec 10;7(12):3314-3335. doi: 10.1021/acsinfecdis.1c00466. Epub 2021 Nov 12.

Pentamidine, an FDA-approved antiparasitic drug, was recently identified as an outer membrane disrupting synergist that potentiates erythromycin, rifampicin, and novobiocin against Gram-negative bacteria. The same study also described a preliminary structure-activity relationship using commercially available pentamidine analogues. We here...

Cite
Wesseling CMJ, Slingerland CJ, Veraar S, et al. Structure-Activity Studies with Bis-Amidines That Potentiate Gram-Positive Specific Antibiotics against Gram-Negative Pathogens. ACS Infect Dis. 2021;7(12):3314-3335doi: 10.1021/acsinfecdis.1c00466.
Wesseling, C. M. J., Slingerland, C. J., Veraar, S., Lok, S., & Martin, N. I. (2021). Structure-Activity Studies with Bis-Amidines That Potentiate Gram-Positive Specific Antibiotics against Gram-Negative Pathogens. ACS infectious diseases, 7(12), 3314-3335. https://doi.org/10.1021/acsinfecdis.1c00466
Wesseling, Charlotte M J, et al. "Structure-Activity Studies with Bis-Amidines That Potentiate Gram-Positive Specific Antibiotics against Gram-Negative Pathogens." ACS infectious diseases vol. 7,12 (2021): 3314-3335. doi: https://doi.org/10.1021/acsinfecdis.1c00466
Wesseling CMJ, Slingerland CJ, Veraar S, Lok S, Martin NI. Structure-Activity Studies with Bis-Amidines That Potentiate Gram-Positive Specific Antibiotics against Gram-Negative Pathogens. ACS Infect Dis. 2021 Dec 10;7(12):3314-3335. doi: 10.1021/acsinfecdis.1c00466. Epub 2021 Nov 12. PMID: 34766746.
Copy Download .nbib Format: NLM
Referral decisions based on a pre-hospital HEART score in suspected non-ST-elevation acute coronary syndrome: final results of the FamouS Triage study.

European heart journal. Acute cardiovascular care

Tolsma RT, Fokkert MJ, van Dongen DN, Badings EA, van der Sluis A, Slingerland RJ, van 't Riet E, Ottervanger JP, van 't Hof AWJ.
PMID: 34849660
Eur Heart J Acute Cardiovasc Care. 2021 Nov 25; doi: 10.1093/ehjacc/zuab109. Epub 2021 Nov 25.

AIMS: Although pre-hospital risk stratification of patients with suspected non-ST-elevation acute coronary syndrome (NSTE-ACS) by ambulance paramedics is feasible, it has not been investigated in daily practice whether referral decisions based on this risk stratification is safe and does...

Cite
Tolsma RT, Fokkert MJ, van Dongen DN, et al. Referral decisions based on a pre-hospital HEART score in suspected non-ST-elevation acute coronary syndrome: final results of the FamouS Triage study. Eur Heart J Acute Cardiovasc Care. 2021;doi: 10.1093/ehjacc/zuab109.
Tolsma, R. T., Fokkert, M. J., van Dongen, D. N., Badings, E. A., van der Sluis, A., Slingerland, R. J., van 't Riet, E., Ottervanger, J. P., & van 't Hof, A. W. J. (2021). Referral decisions based on a pre-hospital HEART score in suspected non-ST-elevation acute coronary syndrome: final results of the FamouS Triage study. European heart journal. Acute cardiovascular care, . https://doi.org/10.1093/ehjacc/zuab109
Tolsma, Rudolf T, et al. "Referral decisions based on a pre-hospital HEART score in suspected non-ST-elevation acute coronary syndrome: final results of the FamouS Triage study." European heart journal. Acute cardiovascular care vol. (2021). doi: https://doi.org/10.1093/ehjacc/zuab109
Tolsma RT, Fokkert MJ, van Dongen DN, Badings EA, van der Sluis A, Slingerland RJ, van 't Riet E, Ottervanger JP, van 't Hof AWJ. Referral decisions based on a pre-hospital HEART score in suspected non-ST-elevation acute coronary syndrome: final results of the FamouS Triage study. Eur Heart J Acute Cardiovasc Care. 2021 Nov 25; doi: 10.1093/ehjacc/zuab109. Epub 2021 Nov 25. PMID: 34849660.
Copy Download .nbib Format: NLM
Treatment of missing data determined conclusions regarding moralizing gods.

Nature

Beheim B, Atkinson QD, Bulbulia J, Gervais W, Gray RD, Henrich J, Lang M, Monroe MW, Muthukrishna M, Norenzayan A, Purzycki BG, Shariff A, Slingerland E, Spicer R, Willard AK.
PMID: 34234331
Nature. 2021 Jul;595(7866):E29-E34. doi: 10.1038/s41586-021-03655-4. Epub 2021 Jul 07.

No abstract available.

Cite
Beheim B, Atkinson QD, Bulbulia J, et al. Treatment of missing data determined conclusions regarding moralizing gods. Nature. 2021;595(7866):E29-E34doi: 10.1038/s41586-021-03655-4.
Beheim, B., Atkinson, Q. D., Bulbulia, J., Gervais, W., Gray, R. D., Henrich, J., Lang, M., Monroe, M. W., Muthukrishna, M., Norenzayan, A., Purzycki, B. G., Shariff, A., Slingerland, E., Spicer, R., & Willard, A. K. (2021). Treatment of missing data determined conclusions regarding moralizing gods. Nature, 595(7866), E29-E34. https://doi.org/10.1038/s41586-021-03655-4
Beheim, Bret, et al. "Treatment of missing data determined conclusions regarding moralizing gods." Nature vol. 595,7866 (2021): E29-E34. doi: https://doi.org/10.1038/s41586-021-03655-4
Beheim B, Atkinson QD, Bulbulia J, Gervais W, Gray RD, Henrich J, Lang M, Monroe MW, Muthukrishna M, Norenzayan A, Purzycki BG, Shariff A, Slingerland E, Spicer R, Willard AK. Treatment of missing data determined conclusions regarding moralizing gods. Nature. 2021 Jul;595(7866):E29-E34. doi: 10.1038/s41586-021-03655-4. Epub 2021 Jul 07. PMID: 34234331.
Copy Download .nbib Format: NLM
Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review.

Cancers

Baltussen JC, Welters MJP, Verdegaal EME, Kapiteijn E, Schrader AMR, Slingerland M, Liefers GJ, van der Burg SH, Portielje JEA, de Glas NA.
PMID: 34944986
Cancers (Basel). 2021 Dec 18;13(24). doi: 10.3390/cancers13246366.

Immune checkpoint inhibitors (ICIs) have strongly improved the survival of melanoma patients. However, as durable response to ICIs are only seen in a minority, there is an unmet need to identify biomarkers that predict response. Therefore, we provide a...

Cite
Baltussen JC, Welters MJP, Verdegaal EME, et al. Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review. Cancers (Basel). 2021;13(24)doi: 10.3390/cancers13246366.
Baltussen, J. C., Welters, M. J. P., Verdegaal, E. M. E., Kapiteijn, E., Schrader, A. M. R., Slingerland, M., Liefers, G. J., van der Burg, S. H., Portielje, J. E. A., & de Glas, N. A. (2021). Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review. Cancers, 13(24), . https://doi.org/10.3390/cancers13246366
Baltussen, Joosje C, et al. "Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review." Cancers vol. 13,24 (2021). doi: https://doi.org/10.3390/cancers13246366
Baltussen JC, Welters MJP, Verdegaal EME, Kapiteijn E, Schrader AMR, Slingerland M, Liefers GJ, van der Burg SH, Portielje JEA, de Glas NA. Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review. Cancers (Basel). 2021 Dec 18;13(24). doi: 10.3390/cancers13246366. PMID: 34944986; PMCID: PMC8699321.
Copy Download .nbib Format: NLM
Obtaining Human Breast Adipose Cells for Breast Cancer Cell Co-culture Studies.

STAR protocols

Picon-Ruiz M, Marchal JA, Slingerland JM.
PMID: 33377091
STAR Protoc. 2020 Dec 11;1(3):100197. doi: 10.1016/j.xpro.2020.100197. eCollection 2020 Dec 18.

Primary human breast cancers invade surrounding fat and contact adipocytes, inflammatory infiltrates, and fibrous stroma. This tissue niche influences breast tumor progression. Here, we present a protocol to enable the

Cite
Picon-Ruiz M, Marchal JA, Slingerland JM. Obtaining Human Breast Adipose Cells for Breast Cancer Cell Co-culture Studies. STAR Protoc. 2020;1(3):100197doi: 10.1016/j.xpro.2020.100197.
Picon-Ruiz, M., Marchal, J. A., & Slingerland, J. M. (2020). Obtaining Human Breast Adipose Cells for Breast Cancer Cell Co-culture Studies. STAR protocols, 1(3), 100197. https://doi.org/10.1016/j.xpro.2020.100197
Picon-Ruiz, Manuel, et al. "Obtaining Human Breast Adipose Cells for Breast Cancer Cell Co-culture Studies." STAR protocols vol. 1,3 (2020): 100197. doi: https://doi.org/10.1016/j.xpro.2020.100197
Picon-Ruiz M, Marchal JA, Slingerland JM. Obtaining Human Breast Adipose Cells for Breast Cancer Cell Co-culture Studies. STAR Protoc. 2020 Dec 11;1(3):100197. doi: 10.1016/j.xpro.2020.100197. eCollection 2020 Dec 18. PMID: 33377091; PMCID: PMC7757558.
Copy Download .nbib Format: NLM
Carbon-free conferencing in the age of COVID-19.

Outlook on agriculture

Veldhuizen LJ, Slingerland M, Barredo L, Giller KE.
PMID: 33281231
Outlook Agric. 2020 Dec;49(4):321-329. doi: 10.1177/0030727020960492. Epub 2020 Sep 21.

The COVID-19 pandemic has been a crash course for many in working from home using various online tools, many of which can be used to organize e-conferences. An e-conference is a fully online event with multiple sessions and virtual...

Cite
Veldhuizen LJ, Slingerland M, Barredo L, et al. Carbon-free conferencing in the age of COVID-19. Outlook Agric. 2020;49(4):321-329doi: 10.1177/0030727020960492.
Veldhuizen, L. J., Slingerland, M., Barredo, L., & Giller, K. E. (2020). Carbon-free conferencing in the age of COVID-19. Outlook on agriculture, 49(4), 321-329. https://doi.org/10.1177/0030727020960492
Veldhuizen, Linda Jl, et al. "Carbon-free conferencing in the age of COVID-19." Outlook on agriculture vol. 49,4 (2020): 321-329. doi: https://doi.org/10.1177/0030727020960492
Veldhuizen LJ, Slingerland M, Barredo L, Giller KE. Carbon-free conferencing in the age of COVID-19. Outlook Agric. 2020 Dec;49(4):321-329. doi: 10.1177/0030727020960492. Epub 2020 Sep 21. PMID: 33281231; PMCID: PMC7684527.
Copy Download .nbib Format: NLM
Use of FreeStyle Libre Flash Monitor Register in the Netherlands (FLARE-NL1): Patient Experiences, Satisfaction, and Cost Analysis.

International journal of endocrinology

Fokkert MJ, Damman A, van Dijk PR, Edens MA, Abbes S, Braakman J, Slingerland RJ, Dikkeschei LD, Dille J, Bilo HJG.
PMID: 31781209
Int J Endocrinol. 2019 Nov 03;2019:4649303. doi: 10.1155/2019/4649303. eCollection 2019.

In patients with diabetes mellitus (DM), adequate glucose control is of major importance. When treatment schemes become more complicated, proper self-management through intermittent self-measurement of blood glucose (SMBG), among others, becomes crucial in achieving this goal. In the last...

Cite
Fokkert MJ, Damman A, van Dijk PR, et al. Use of FreeStyle Libre Flash Monitor Register in the Netherlands (FLARE-NL1): Patient Experiences, Satisfaction, and Cost Analysis. Int J Endocrinol. 2019;2019:4649303doi: 10.1155/2019/4649303.
Fokkert, M. J., Damman, A., van Dijk, P. R., Edens, M. A., Abbes, S., Braakman, J., Slingerland, R. J., Dikkeschei, L. D., Dille, J., & Bilo, H. J. G. (2019). Use of FreeStyle Libre Flash Monitor Register in the Netherlands (FLARE-NL1): Patient Experiences, Satisfaction, and Cost Analysis. International journal of endocrinology, 20194649303. https://doi.org/10.1155/2019/4649303
Fokkert, M J, et al. "Use of FreeStyle Libre Flash Monitor Register in the Netherlands (FLARE-NL1): Patient Experiences, Satisfaction, and Cost Analysis." International journal of endocrinology vol. 2019 (2019): 4649303. doi: https://doi.org/10.1155/2019/4649303
Fokkert MJ, Damman A, van Dijk PR, Edens MA, Abbes S, Braakman J, Slingerland RJ, Dikkeschei LD, Dille J, Bilo HJG. Use of FreeStyle Libre Flash Monitor Register in the Netherlands (FLARE-NL1): Patient Experiences, Satisfaction, and Cost Analysis. Int J Endocrinol. 2019 Nov 03;2019:4649303. doi: 10.1155/2019/4649303. eCollection 2019. PMID: 31781209; PMCID: PMC6875221.
Copy Download .nbib Format: NLM
Estrogen induces dynamic ERα and RING1B recruitment to control gene and enhancer activities in luminal breast cancer.

Science advances

Zhang Y, Chan HL, Garcia-Martinez L, Karl DL, Weich N, Slingerland JM, Verdun RE, Morey L.
PMID: 32548262
Sci Adv. 2020 Jun 05;6(23):eaaz7249. doi: 10.1126/sciadv.aaz7249. eCollection 2020 Jun.

RING1B, a core Polycomb repressive complex 1 subunit, is a histone H2A ubiquitin ligase essential for development. RING1B is overexpressed in patients with luminal breast cancer (BC) and recruited to actively transcribed genes and enhancers co-occupied by the estrogen...

Cite
Zhang Y, Chan HL, Garcia-Martinez L, et al. Estrogen induces dynamic ERα and RING1B recruitment to control gene and enhancer activities in luminal breast cancer. Sci Adv. 2020;6(23):eaaz7249doi: 10.1126/sciadv.aaz7249.
Zhang, Y., Chan, H. L., Garcia-Martinez, L., Karl, D. L., Weich, N., Slingerland, J. M., Verdun, R. E., & Morey, L. (2020). Estrogen induces dynamic ERα and RING1B recruitment to control gene and enhancer activities in luminal breast cancer. Science advances, 6(23), eaaz7249. https://doi.org/10.1126/sciadv.aaz7249
Zhang, Yusheng, et al. "Estrogen induces dynamic ERα and RING1B recruitment to control gene and enhancer activities in luminal breast cancer." Science advances vol. 6,23 (2020): eaaz7249. doi: https://doi.org/10.1126/sciadv.aaz7249
Zhang Y, Chan HL, Garcia-Martinez L, Karl DL, Weich N, Slingerland JM, Verdun RE, Morey L. Estrogen induces dynamic ERα and RING1B recruitment to control gene and enhancer activities in luminal breast cancer. Sci Adv. 2020 Jun 05;6(23):eaaz7249. doi: 10.1126/sciadv.aaz7249. eCollection 2020 Jun. PMID: 32548262; PMCID: PMC7274770.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 61 entries